Erectile Dysfunction Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019
Erectile Dysfunction Drugs Market (Viagra, Cialis, Levitra/Staxyn, Stendra/Spedra, Zydena, MUSE, Mvix and Helleva) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019
Erectile Dysfunction Drugs Market (Viagra, Cialis, Levitra/Staxyn, Stendra/Spedra, Zydena, MUSE, Mvix and Helleva) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Erectile</strong> <strong>Dysfunction</strong> <strong>Drugs</strong> <strong>Market</strong><br />
FIG. 1 <strong>Erectile</strong> <strong>Dysfunction</strong> <strong>Drugs</strong> <strong>Market</strong> Segmentation<br />
FIG. 2 <strong>Global</strong> <strong>Erectile</strong> <strong>Dysfunction</strong> <strong>Drugs</strong> <strong>Market</strong> Revenue, 2010 - <strong>2019</strong> (USD Million)<br />
FIG. 3 Porter’s Five Forces <strong>Analysis</strong>: <strong>Global</strong> <strong>Erectile</strong> <strong>Dysfunction</strong> <strong>Drugs</strong> <strong>Market</strong><br />
FIG. 4 <strong>Market</strong> Attractiveness <strong>Analysis</strong>: <strong>Global</strong> <strong>Erectile</strong> <strong>Dysfunction</strong> <strong>Drugs</strong> <strong>Market</strong>, By Geography (2015)<br />
FIG. 5 PPDE 5 Inhibitors: Mechanism of Action<br />
FIG. 6 <strong>Global</strong> Viagra <strong>Market</strong> For <strong>Erectile</strong> <strong>Dysfunction</strong> Treatment, 2010 <strong>–</strong> <strong>2019</strong> (USD Million)<br />
FIG. 7 <strong>Global</strong> Viagra <strong>Market</strong> For <strong>Erectile</strong> <strong>Dysfunction</strong> Treatment, 2010 <strong>–</strong> 2014 (USD Million)<br />
FIG. 8 <strong>Global</strong> Viagra <strong>Market</strong> For <strong>Erectile</strong> <strong>Dysfunction</strong> Treatment, 2015 <strong>–</strong> <strong>2019</strong> (USD Million)<br />
FIG. 9 <strong>Global</strong> Cialis <strong>Market</strong> For <strong>Erectile</strong> <strong>Dysfunction</strong> Treatment, 2010 <strong>–</strong> <strong>2019</strong> (USD Million)<br />
FIG. 10 <strong>Global</strong> Cialis <strong>Market</strong> For <strong>Erectile</strong> <strong>Dysfunction</strong> Treatment, 2010 <strong>–</strong> 2014 (USD Million)<br />
FIG. 11 <strong>Global</strong> Cialis <strong>Market</strong> For <strong>Erectile</strong> <strong>Dysfunction</strong> Treatment, 2015 <strong>–</strong> <strong>2019</strong> (USD Million)<br />
FIG. 12 <strong>Global</strong> Levitra/Staxyn <strong>Market</strong> For <strong>Erectile</strong> <strong>Dysfunction</strong> Treatment, 2010 <strong>–</strong> <strong>2019</strong> (USD Million)<br />
FIG. 13 <strong>Global</strong> Levitra/Staxyn <strong>Market</strong> For <strong>Erectile</strong> <strong>Dysfunction</strong> Treatment, 2010 <strong>–</strong> 2014 (USD Million)<br />
FIG. 14 <strong>Global</strong> Levitra/Staxyn <strong>Market</strong> For <strong>Erectile</strong> <strong>Dysfunction</strong> Treatment, 2015 <strong>–</strong> <strong>2019</strong> (USD Million)<br />
FIG. 15 <strong>Global</strong> Stendra/Spedra <strong>Market</strong> For <strong>Erectile</strong> <strong>Dysfunction</strong> Treatment, 2015 <strong>–</strong> <strong>2019</strong> (USD Million)<br />
FIG. 16 <strong>Global</strong> Zydena <strong>Market</strong> For <strong>Erectile</strong> <strong>Dysfunction</strong> Treatment, 2010 <strong>–</strong> <strong>2019</strong> (USD Million)<br />
FIG. 17 <strong>Global</strong> Zydena <strong>Market</strong> For <strong>Erectile</strong> <strong>Dysfunction</strong> Treatment, 2010 <strong>–</strong> 2014 (USD Million)<br />
FIG. 18 <strong>Global</strong> Zydena <strong>Market</strong> For <strong>Erectile</strong> <strong>Dysfunction</strong> Treatment, 2015 <strong>–</strong> <strong>2019</strong> (USD Million)<br />
FIG. 19 <strong>Global</strong> Vitaros <strong>Market</strong> For <strong>Erectile</strong> <strong>Dysfunction</strong> Treatment, 2014 <strong>–</strong> <strong>2019</strong> (USD Million)<br />
FIG. 20 Comparative <strong>Analysis</strong>: <strong>Global</strong> <strong>Erectile</strong> <strong>Dysfunction</strong> <strong>Drugs</strong> <strong>Market</strong>, By Geography, 2012 & <strong>2019</strong><br />
(Value %)<br />
Transparency <strong>Market</strong> Research<br />
13
Change language